Skip to content
10-K

Annual Report

CURAXIS PHARMACEUTICAL CORP

0001354488-12-001468

← back to feed
Filed
Mar 29, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 28, 2012 83.55M sh
Shares Diluted FY 2011 · Dec 31, 2011 80.08K sh
Shares Diluted FY 2011 · Dec 31, 2010 67.32K sh
Stock Repurchased FY 2011 · Dec 31, 2011 $388K
Capex FY 2011 · Dec 31, 2011 $1.2M
Capex FY 2011 · Dec 31, 2010 $2K
Operating Cash Flow FY 2011 · Dec 31, 2011 −$857K
Operating Cash Flow FY 2011 · Dec 31, 2011 −$78.13M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$1.32M
Cash And Equivalents FY 2011 · Dec 31, 2011 $22K
Cash And Equivalents FY 2011 · Dec 31, 2010 $2K
Cash And Equivalents FY 2011 · Dec 31, 2009 $631K
Stockholders Equity FY 2011 · Dec 31, 2011 −$8.26M
Stockholders Equity FY 2011 · Dec 31, 2010 −$10.44M
Stockholders Equity FY 2011 · Dec 31, 2009 −$9.59M
Current Liabilities FY 2011 · Dec 31, 2011 $6.59M
Current Liabilities FY 2011 · Dec 31, 2010 $6.55M
Total Liabilities FY 2011 · Dec 31, 2011 $8.92M
Total Liabilities FY 2011 · Dec 31, 2010 $11.37M
Current Assets FY 2011 · Dec 31, 2011 $343K
Current Assets FY 2011 · Dec 31, 2010 $309K
Total Assets FY 2011 · Dec 31, 2011 $658K
Total Assets FY 2011 · Dec 31, 2010 $923K
Eps Diluted FY 2011 · Dec 31, 2011 $0.02
Eps Diluted FY 2011 · Dec 31, 2010 −$0.03
Eps Basic FY 2011 · Dec 31, 2011 $0.02
Eps Basic FY 2011 · Dec 31, 2010 −$0.03
Sga Expense FY 2011 · Dec 31, 2011 $1.89M
Sga Expense FY 2011 · Dec 31, 2011 $28.57M
Sga Expense FY 2011 · Dec 31, 2010 $1.86M
Rd Expense FY 2011 · Dec 31, 2011 $33K
Rd Expense FY 2011 · Dec 31, 2011 $61.47M
Rd Expense FY 2011 · Dec 31, 2010 $78K
Net Income FY 2011 · Dec 31, 2011 $1.33M
Net Income FY 2011 · Dec 31, 2011 −$88.46M
Net Income FY 2011 · Dec 31, 2010 −$2.24M
Operating Income FY 2011 · Dec 31, 2011 −$1.92M
Operating Income FY 2011 · Dec 31, 2011 −$97.05M
Operating Income FY 2011 · Dec 31, 2010 −$1.94M